Extrapolation of indications in biosimilars: epoetin

posted 12/12/2014

Despite a stringent approval process, acceptance of biosimilars in the medical community continues to be low, and especially in extrapolated* indications. Me...

Canada’s generics are too expensive Generics/Research | Posted 12/12/2014
Non-biological complex drug concept: experience... Biosimilars/Research | Posted 12/12/2014
Trade groups comment on China’s biosimilars gui... Policies & Legislation | Posted 12/12/2014
EU Member States suspend generics approvals due... Generics/General | Posted 12/12/2014
Momenta gains approval to start biosimilar adal... Biosimilars/News | Posted 12/12/2014
First celecoxib generics hit US market Generics/News | Posted 12/12/2014
EBG–Biosimilars 2015 Conferences | Posted 12/12/2014
US biosimilar uptake in the light of Obamacare Biosimilars/Research | Posted 05/12/2014
Irish pharmacists’ perceptions and attitudes to... Generics/Research | Posted 05/12/2014
Biosimilar infliximab launched in Japan Biosimilars/News | Posted 05/12/2014
Use of biosimilars in rheumatology Biosimilars/Research | Posted 05/12/2014
Generics makers challenging more patents Reports | Posted 05/12/2014
Stada to in-license adalimumab biosimilar Biosimilars/News | Posted 05/12/2014
FDA delays finalization of generics labelling rule Policies & Legislation | Posted 05/12/2014
Comparison of biosimilar filgrastim versus othe... Biosimilars/Research | Posted 28/11/2014
EuropaBio calls for distinguishable names for b... Biosimilars/General | Posted 28/11/2014
Generics losing out to brand-name drugs in Croatia Generics/Research | Posted 28/11/2014
Developments in the US over state biosimilars s... Policies & Legislation | Posted 28/11/2014
FDA withdraws automatic substitution of two met... Generics/News | Posted 28/11/2014
Amgen expands biosimilars programme Biosimilars/News | Posted 28/11/2014
Actavis buys Allergan and joins pharma top 10 Pharma News | Posted 28/11/2014
Extrapolation of indications in biosimilars: fi... Biosimilars/Research | Posted 21/11/2014
More discussion over WHO biological qualifier Biosimilars/General | Posted 21/11/2014
Chinese guidelines for biosimilars Guidelines | Posted 21/11/2014
EMA criticized for redaction of AbbVie’s data Policies & Legislation | Posted 21/11/2014
Amgen launches biosimilars info app Biosimilars/News | Posted 21/11/2014
Investigation into huge price increases for gen... Generics/General | Posted 21/11/2014
Cipla petitions Indian Government to revoke Onb... Generics/News | Posted 21/11/2014
China releases draft biosimilars guidance Guidelines | Posted 14/11/2014
Biosimilars: when indications can be extrapolated Biosimilars/Research | Posted 14/11/2014
Amgen sues Sandoz over filgrastim biosimilar Biosimilars/News | Posted 14/11/2014
Canada partially lifts import ban on Indian man... Generics/General | Posted 14/11/2014
Biosimilars use in Europe varies widely Reports | Posted 14/11/2014
Another old drug to see huge price increase in US Policies & Legislation | Posted 14/11/2014
Biosimilars: similar but not identical Biosimilars/Research | Posted 07/11/2014
Predicting the response of diabetes patients to... Biosimilars/Research | Posted 07/11/2014
India’s policies prevent secondary patenting an... Policies & Legislation | Posted 07/11/2014
Study into switching from Aranesp to biosimilar... Biosimilars/News | Posted 07/11/2014
Coherus sells shares to raise funds for biosimi... Biosimilars/News | Posted 07/11/2014
Improved labelling sought for biosimilar accept... Biosimilars/Research | Posted 31/10/2014

Generics News Research General


Biosimilars News Research General